Additionally, piperine treatment increased miR-181b expression while reducing miR-92b and TNF-α expression.<h4>Conclusion</h4>Our findings suggest that inhibiting miR-92b, miR-181b, TNF-α, and BAX using LNA-anti-miR could be a promising strategy for treating ALL. This evidence concerns the gene TNF and acute lymphoblastic leukemia.